Aditxt Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 0.23, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2026. Average receivable collection period, for the Aditxt Inc in Mar 31 2026 quarter, has decreased to 1587 days, compared to 9125 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 656 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from to 4213.

What is Receivable Turnover Ratio?
What is Aditxt Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ADTX Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-90 %	-	-66.53 %	-71.05 %	-71.9 %
Y / Y Revenue Change	1120 %	-83.87 %	-89.86 %	-97.74 %	-98.74 %
Receivable Turnover Ratio (TTM)	0.23	0.04	0.05	0.07	0.22
ADTX's Total Ranking	# 4213	#	#	#	#
Accounts Receivable average collection period days	1568	10134	7505	5407	1651
Seq. Receivable Change	-	-	0 %	-1.92 %	-1.32 %
Seq. Revenue Change	2340 %	-28.57 %	-30 %	0 %	-67.74 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 260
Healthcare Sector	# 657
Overall Market	# 4213

Receivable Turnover Ratio Statistics
High	Average	Low
0.09	0.03	0
(Sep 30 2023)		(Dec 31 2025)

ADTX Company Profile • Back to ADTX Efficiency Comparisons • Compare ADTX Receivables Turnover Ratio to its Competitors

Financial Statements
Aditxt Inc 's Accounts Receivable	$ 0 Millions	Visit ADTX's Balance sheet
Aditxt Inc 's Sales TTM	$ 0 Millions	Visit ADTX's Income Statement
Sources of ADTX's Revenues		Visit ADTX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ADTX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ADTX's Growth Rates	ADTX's Roa	ADTX's Inventory Turnover Ratio	ADTX's Dividend Comparisons
ADTX's Profitability Ratios	ADTX's Roi	ADTX's Asset Turnover Ratio	ADTX's Dividend Growth
ADTX's Valuation Ratios	ADTX's Roe	ADTX's Financial Strength Ratios	ADTX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Axsome Therapeutics Inc	3.25	$ 708.236 Millions	$ 217.715 Millions
Recursion Pharmaceuticals Inc	3.25	$ 66.408 Millions	$ 20.438 Millions
Arcutis Biotherapeutics Inc	3.24	$ 415.624 Millions	$ 128.103 Millions
Apellis Pharmaceuticals Inc	3.24	$ 1,105.280 Millions	$ 341.547 Millions
Cumberland Pharmaceuticals Inc	3.23	$ 41.940 Millions	$ 12.989 Millions
Tenon Medical Inc	3.20	$ 4.597 Millions	$ 1.437 Millions
Keenova Therapeutics Plc	3.12	$ 1,413.000 Millions	$ 453.200 Millions
Surrozen Inc	3.11	$ 7.494 Millions	$ 2.409 Millions
Establishment Labs Holdings Inc	3.09	$ 228.835 Millions	$ 74.027 Millions
Phathom Pharmaceuticals Inc	3.08	$ 204.892 Millions	$ 66.474 Millions
Cormedix Inc	2.96	$ 389.749 Millions	$ 131.881 Millions
Journey Medical Corp	2.93	$ 64.680 Millions	$ 22.101 Millions
Harrow Inc	2.90	$ 267.575 Millions	$ 92.144 Millions
Sensus Healthcare Inc	2.90	$ 22.907 Millions	$ 7.894 Millions
Adc Therapeutics Sa	2.90	$ 79.175 Millions	$ 27.316 Millions
Docgo Inc	2.90	$ 301.713 Millions	$ 104.158 Millions
Cartesian Therapeutics Inc	2.90	$ 1.775 Millions	$ 0.613 Millions
Seer Inc	2.88	$ 14.386 Millions	$ 5.004 Millions
Allurion Technologies Inc	2.86	$ 12.357 Millions	$ 4.314 Millions
Anteris Technologies Global Corp	2.80	$ 1.851 Millions	$ 0.660 Millions
Astrotech Corp	2.73	$ 1.008 Millions	$ 0.369 Millions
Electromed Inc	2.73	$ 70.478 Millions	$ 25.841 Millions
Autolus Therapeutics Plc	2.68	$ 92.624 Millions	$ 34.624 Millions
Regeneron Pharmaceuticals Inc	2.62	$ 14,919.600 Millions	$ 5,692.300 Millions
Marker Therapeutics inc	2.60	$ 3.949 Millions	$ 1.522 Millions
Fennec Pharmaceuticals Inc	2.59	$ 50.999 Millions	$ 19.707 Millions
Brightspring Health Services Inc	2.54	$ 2,595.630 Millions	$ 1,022.222 Millions
Aclarion Inc	2.53	$ 0.078 Millions	$ 0.031 Millions
Profound Medical Corp	2.39	$ 18.814 Millions	$ 7.880 Millions
Tg Therapeutics Inc	2.35	$ 700.349 Millions	$ 298.644 Millions

Date modified: 2026-08-30T15:02:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.